Janine Jjingo is a corporate and finance attorney, primarily representing investment banks, commercial banks, private equity funds, financial institution investors, and public and private corporations in a wide range of U.S. and cross-border transactions in connection with secured and unsecured financings, acquisition financings, asset-backed loans, restructuring and debtor-in-possession financings and other types of complex and traditional financings.

Bio

Ms. Jjingo regularly advises a variety of financial institutions, including Bank of America, Barclays, Citibank, Credit Suisse, Goldman Sachs, HSBC, ING and Morgan Stanley. She was recognized as a Rising Star in IFLR1000, as well as a Rising Star in Finance at Euromoney Legal Media Group’s 2019 Americas Women in Business Law Awards.

Her representations have included:

  • York Capital Management in its sale of The Bay Club Company to KKR & Co. Inc.;
  • Visteon Corporation in various amendments to its credit agreement including the replacement and repricing of the existing term facility with a new $350 million term loan facility; and in the $3.6 billion sale of its 70 percent stake in Halla Visteon Climate Control Corp. (South Korea);
  • Key Safety Systems, Inc. in its $1.6 billion acquisition of substantially all of the assets and operations of Takata Corporation (Japan), as part of Takata’s Chapter 11 case;
  • BlackRock, Inc. in a variety of matters involving revolving credit facilities and its $20 billion acquisition of Barclays Global Investors;
  • Synergy Pharmaceuticals in its Chapter 11 filing, DIP financing and sale of substantially all of its assets to Bausch Health;
  • Pinnacle Entertainment, Inc. in its $2.8 billion acquisition by Penn National Gaming, Inc.;
  • DST Systems, Inc. in its $5.4 billion acquisition by SS&C Technologies Holdings, Inc.;
  • Permira Funds in connection with a first lien $325 million term loan and $50 million revolving facility, in addition to a second lien $120 million term loan to finance its acquisition of DiversiTech Holdings, Inc.;
  • Gilead in a variety of matters, including its $11.9 billion acquisition of Kite Pharma, Inc. and its $11 billion acquisition for Pharmasset, Inc.;
  • Valeant Pharmaceuticals International, Inc. in its:
    • $2.6 billion acquisition of Medicis Pharmaceutical Corporation;
    • $800 million acquisition of Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical Company S.A.E. (Egypt); and
    • its $15 billion acquisition of Salix Pharmaceuticals Ltd.;
  • A&E Television Networks in connection with the financing of NBCUniversal Media, LLC’s $3 billion sale of its 15.8 percent stake in A&E to The Walt Disney Corporation and Hearst Corporation; and
  • E.I. DuPont de Nemours and Company in its:
    • $7.4 billion acquisition of Danisco A/S, a manufacturer of food ingredients; and
    • in a $3.5 billion revolving credit facility from JPMorgan Chase Bank, N.A.

Credentials

Education

  • J.D., Columbia Law School, 2005
  • B.A., University of Pennsylvania, 2002 (magna cum laude)

Admissions

  • New York

M. Janine Jjingo